Press "Enter" to skip to content

Merck to buy cancer drug developer ArQule for $2.7 bln in cash

Merck’s blockbuster cancer immunotherapy Keytruda topped $3 billion in sales in the latest quarter.

Original source: https://health.economictimes.indiatimes.com/news/pharma/merck-to-buy-cancer-drug-developer-arqule-for-2-7-bln-in-cash/72456967?utm_source=RSS&utm_medium=ETRSS

Also Read:   Pharma giant to start Favipiravir clinical trials for COVID-19: How does it work?